| Product NDC: | 23155-108 |
| Proprietary Name: | Nimodipine |
| Non Proprietary Name: | Nimodipine |
| Active Ingredient(s): | 30 mg/1 & nbsp; Nimodipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 23155-108 |
| Labeler Name: | Heritage |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076740 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080321 |
| Package NDC: | 23155-108-30 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (23155-108-30) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11) |
| NDC Code | 23155-108-30 |
| Proprietary Name | Nimodipine |
| Package Description | 3 BLISTER PACK in 1 CARTON (23155-108-30) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (23155-108-11) |
| Product NDC | 23155-108 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nimodipine |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20080321 |
| Marketing Category Name | ANDA |
| Labeler Name | Heritage |
| Substance Name | NIMODIPINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |